Category: Advocacy
-
M-Coalition launch a new guide: Key Population Engagement in Global Fund Country Dialogue CCMs and the 2017-‐2019 funding cycle
Source : M-Colaition This resource guide is designed to assist civil society organizations in understanding how to access funding from the Global Fund (GF) and effectively engage in country dialogue through all the key stages. In 2014, the Global Fund’s New Funding Model (NFM) was launched. Inclusion of civil society and key affected populations (KAP)…
-
Amendment of the TRIPS Agreement
WTO members on 6 December 2005 approved changes to the WTO’s intellectual property (TRIPS) agreement in order to make permanent a decision on patents and public health originally adopted in 2003. This was formally built into the TRIPS Agreement after acceptance of the Protocol amending the TRIPS Agreement by two thirds of the WTO’s members.…
-
Middle East and North Africa Position Statement on HIV/AIDS to the High-Level Meeting on AIDS
Middle East and North Africa Position Statement on HIV/AIDS to the UN General Assembly Special Session High-Level Meeting on AIDS 6 – 8 June 2016 We, the undersigned communities of the MENA region; regional an d national networks and civil society organizations and representatives of key populations1, youth organizations, PLHIV organizations and groups convened on…
-
Civil Society Calls on WHO to Include Report from UN’s High Level Panel on Medicines on WHO Board Agenda
Dear Director General Dr. Margaret Chan Request to include discussion of the United Nations Secretary-General’s High Level Panel Report on Access to Medicines at the next WHO Board meeting As members of the Make Medicines Affordable campaign, and other Civil Society and Community Based Organizations working on access to medicines in developing countries, we express…
-
Morocco: Creation of a collective for t the right to health in the framework of the negotiations of the EU ALECA
At a time when the Kingdom of Morocco and the European Union are preparing to resume negotiations on the “comprehensive and thorough free trade agreement” (FTAA), Moroccan civil society unites to bell Alarm about ALECA’s danger of access to generics in our country. A collective for the preservation of the right to health in Morocco in…
-
African Treatment Advocates Call on ViiV Healthcare to Unlock Access to Dolutegravir for North Africa Now
Harare, December 1st, 2015 Today, at the International Conference on AIDS and STIs in Africa (ICASA), treatment advocates and activists from all over Africa united to urge ViiV Healthcare to allow affordable access to an essential drug in four North African countries. A voluntary license from Viiv Healthcare will enable all other countries in Africa…
-
Building Capacity on Intellectual Property, Free Trade Agreement and Access to Medicines Workshop
ATL MST – ITPC MENA WORKSHOP TUNISIA 16, 17 & 18 NOVEMBER 2015 One of the most pressing issues in the 21st century is the lack of availability of essential medicines to poor patients in underdeveloped and developing countries. The problem is attributed to the existing Intellectual Property Rights (IPR) regimes, which were not aligned…
-
WHO Launches New HIV Treatment and Prevention Guidelines
The WHO has made two important new treatment recommendations that will affect all HIV treatment programmes. The recommendations are entitled the ’Early Release’ Guidelines on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. The recommendations in this guideline will form part of the revised consolidated guidelines on the use of ARV drugs…
-
Treatment Advocates Denounce Gilead’s Embargo against Thousands of Tunisians Suffering from HCV Infection
The Tunisian Association of Fight against STDs and AIDS (ATL Tunis) and the International Treatment Preparedness Coalition in MENA Region (ITPC-MENA) denounce the refusal of Gilead Sciences to make their drug against the Hepatitis C Virus (HCV), sofosbuvir, available to Tunisian patients. “For months, thousands of patients have been desperately waiting for access to sofosbuvir.…
-
The first Middle East and North Africa Community Advisory Board (MENA-CAB)
Casablanca, Morocco, 28 June-01 July 2014 Despite the fact that HIV prevalence in the countries of the Middle East and North Africa is believed to be low at least among the General Population, the rate of increase of new cases since 2001 makes this region home to one of the most fastest-growing epidemic in the…